Sign In

Login

Password

Forgot Password ? Sign Up

エナラプリル (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "エナラプリル" in Japanese language version.

refsWebsite
Global rank Japanese rank
5nih.gov
4th place
24th place
1who.int
195th place
376th place
1pmda.go.jp
6,690th place
394th place
1nejm.org
2,374th place
2,486th place
1doi.org
2nd place
6th place
1medscape.com
719th place
3,311th place
1aspetjournals.org
6,663rd place
low place
1books.google.com
3rd place
61st place
1pharmaceutical-journal.com
low place
low place

aspetjournals.org

dmd.aspetjournals.org

books.google.com

  • Menard J and Patchett A. Angiotensin-Converting Enzyme Inhibitors. Pp 14-76 in Drug Discovery and Design. Volume 56 of Advances in Protein Chemistry. Eds Richards FM, Eisenberg DS, and Kim PS. Series Ed. Scolnick EM. Academic Press, 2001. ISBN 9780080493381. Pg 30

doi.org

  • John J.V. McMurray (January 21, 2010). “Clinical Practice: Systolic Heart Failure”. N Engl J Med 362 (3): 228–238. doi:10.1056/NEJMcp0909392. PMID 20089973. http://www.nejm.org/doi/full/10.1056/NEJMcp0909392. "Two large trials showed that when patients with NYHA class II, III, or IV heart failure were treated with enalapril, as compared with placebo, in addition to diuretics and digoxin, the rates of admission to the hospital were reduced, and there was a relative risk reduction for death of 16 to 40%." 

medscape.com

nejm.org

  • John J.V. McMurray (January 21, 2010). “Clinical Practice: Systolic Heart Failure”. N Engl J Med 362 (3): 228–238. doi:10.1056/NEJMcp0909392. PMID 20089973. http://www.nejm.org/doi/full/10.1056/NEJMcp0909392. "Two large trials showed that when patients with NYHA class II, III, or IV heart failure were treated with enalapril, as compared with placebo, in addition to diuretics and digoxin, the rates of admission to the hospital were reduced, and there was a relative risk reduction for death of 16 to 40%." 

nih.gov

pubmed.ncbi.nlm.nih.gov

  • John J.V. McMurray (January 21, 2010). “Clinical Practice: Systolic Heart Failure”. N Engl J Med 362 (3): 228–238. doi:10.1056/NEJMcp0909392. PMID 20089973. http://www.nejm.org/doi/full/10.1056/NEJMcp0909392. "Two large trials showed that when patients with NYHA class II, III, or IV heart failure were treated with enalapril, as compared with placebo, in addition to diuretics and digoxin, the rates of admission to the hospital were reduced, and there was a relative risk reduction for death of 16 to 40%." 
  • He YM et al. Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis. Nephrology (Carlton). 2013 Sep;18(9):605-14. doi: 10.1111/nep.12134. PMID 23869492
  • D. J. Tocco (1982). “The physiological disposition and metabolism of enalapril maleate in laboratory animals”. Drug Metab Dispos. 10 (15): 15–19. PMID 6124377. http://dmd.aspetjournals.org/content/10/1/15.abstract 2016年5月25日閲覧。. 

nlm.nih.gov

dailymed.nlm.nih.gov

pharmaceutical-journal.com

pmda.go.jp

info.pmda.go.jp

who.int

apps.who.int